| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/26/2008 | US7335359 Glycosylated specificity exchangers |
| 02/26/2008 | US7335358 Methods of treating psoriasis with anti-TNF antibodies |
| 02/26/2008 | US7335357 Antagonists of neuropilin receptor function and use thereof |
| 02/26/2008 | US7335355 Antimicrobial agent |
| 02/26/2008 | US7335351 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme |
| 02/26/2008 | US7335350 Treating multiple sclerosis by orally administering an excipient and a RANTES polypeptide; preventing autoimmune and inflammatory diseases and bacterial and viral infections |
| 02/26/2008 | CA2230159C Use of aminoadamantane compounds as immunoregulators |
| 02/26/2008 | CA2078544C Method and compositions for treating injury |
| 02/24/2008 | CA2558043A1 Methods of correcting bone mineralization defects, kits therefor and compositions therefor |
| 02/21/2008 | WO2008022303A2 Anti-h5n1 influenza activity of the antiviral protein cyanovirin |
| 02/21/2008 | WO2008022151A1 Prophylactic treatment of hemophilia |
| 02/21/2008 | WO2008022030A2 Promiscuous pap cd4 t cell epitopes |
| 02/21/2008 | WO2008022019A2 Promiscuous her-2/neu cd4 t cell epitopes |
| 02/21/2008 | WO2008022015A2 Retro-inverso incretin analogues, and methods of use thereof |
| 02/21/2008 | WO2008022006A2 Arylalkoxyl hepatitis c virus protease inhibitors |
| 02/21/2008 | WO2008021960A2 Triazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/21/2008 | WO2008021896A2 Therapeutic methods for neuropathic pain |
| 02/21/2008 | WO2008021872A1 Diuretic and natriuretic polypeptides |
| 02/21/2008 | WO2008021871A2 Triazolyl acyclic hepatitis c serine protease inhibitors |
| 02/21/2008 | WO2008021795A2 Flowable carrier matrix |
| 02/21/2008 | WO2008021733A2 Tetrazolyl acyclic hepatitis c serine protease inhibitors |
| 02/21/2008 | WO2008021560A2 Dpp-iv resistant gip hybrid polypeptides with selectable properties |
| 02/21/2008 | WO2008021550A2 Thiol-based agents for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 02/21/2008 | WO2008021487A1 Combination treatment method with interferon-tau |
| 02/21/2008 | WO2008021088A2 Salicylanilides enhance oral delivery of therapeutic peptides |
| 02/21/2008 | WO2008020954A2 Cosmetic composition to accelerate repair of functional wrinkles |
| 02/21/2008 | WO2008020942A2 R-spondin compositions and methods of use thereof |
| 02/21/2008 | WO2008020802A1 Cardioprotective compounds |
| 02/21/2008 | WO2008020778A1 Analgetically active peptide family |
| 02/21/2008 | WO2008020769A1 Methods for reducing the incidence of mastitis |
| 02/21/2008 | WO2008020638A1 Therapeutic agent for ligament injury |
| 02/21/2008 | WO2008020596A2 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 02/21/2008 | WO2008020489A1 Remedy for inflammatory bowel disease |
| 02/21/2008 | WO2008020260A2 Use of siderophores in prevention of vascular diseases, production of siderophores and qualifying siderophore containing meat-products |
| 02/21/2008 | WO2008020221A2 Topical application of fsh, lh, tsh or cg to the cervix |
| 02/21/2008 | WO2008020119A1 Activated fibroblasts for treating tissue and/or organ damage |
| 02/21/2008 | WO2008020085A2 Use of chloro- and fluoromethyl ketone derivatives in anti-viral therapy |
| 02/21/2008 | WO2008019491A1 Inhibition of angiogenesis, tumorigenesis and cathepsin activity using insulin-like growth factor binding protein |
| 02/21/2008 | WO2008019434A1 The use of growth factors in a method of improving fat-graft survival |
| 02/21/2008 | WO2008019431A1 Method and compositions for simultaneously regulating memory and mood |
| 02/21/2008 | WO2008019417A2 Treatment of ocular diseases |
| 02/21/2008 | WO2008005470A3 Polypeptides that bind membrane proteins |
| 02/21/2008 | WO2008000881B1 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 02/21/2008 | WO2007150049A3 Lactoferrin as a radioprotective agent |
| 02/21/2008 | WO2007149512A3 Peptide epoxyketones for pr0teas0me inhibition |
| 02/21/2008 | WO2007140410A9 Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods |
| 02/21/2008 | WO2007139805A3 Methods of dissolving beta-sheet proteins and uses thereof |
| 02/21/2008 | WO2007127457A3 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
| 02/21/2008 | WO2007123667A3 Membrane-permeant peptide complexes for treatment of sepsis |
| 02/21/2008 | WO2007109221A3 Methods for reducing protein aggregation |
| 02/21/2008 | WO2007103523A3 Antioxidant protein, compositions, and methods of use |
| 02/21/2008 | WO2007092609A3 Method for treating peripheral arterial disease with zinc finger proteins |
| 02/21/2008 | WO2007084388A3 Nogo-b receptor |
| 02/21/2008 | WO2007079312A3 Compositions and methods for treating actin-mediated medical conditions |
| 02/21/2008 | WO2007042010A3 Synergistic pharmaceutical composition containing a peptide with 2 to 5 amino acids |
| 02/21/2008 | WO2006130504A3 Methods for identifying ligands for stem cells and cells derived therefrom |
| 02/21/2008 | WO2006081190A3 Compositions and methods for treating cardiac conditions |
| 02/21/2008 | WO2006044334A3 Platelet-derived growth factor compositions and methods of use thereof |
| 02/21/2008 | WO2005089445A3 Follicle stimulating hormone superagonists |
| 02/21/2008 | WO2005020898A3 Methods of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i) |
| 02/21/2008 | WO2005016247A3 Dna sequences, peptides, antibodies and vaccines for prevention and treatment of sars |
| 02/21/2008 | US20080045926 Treatment of Conditions Involving Dopaminergic Neuronal Degeneration Using Nogo Receptor Antagonists |
| 02/21/2008 | US20080045721 Thiazole-oxime chemical intermediates to cephalosporin-linked vancomycin derivatives which have use against antibiotic-resistant bacteria including methicillin-resistant Staphylococci aureus (MRSA) |
| 02/21/2008 | US20080045699 Interleukin-1 Related Gene and Protein |
| 02/21/2008 | US20080045698 Mammalian receptor proteins; related reagents and methods |
| 02/21/2008 | US20080045608 Gene Encoding a Guanine Nucleotide Exchange Factor Binding to Rhoa |
| 02/21/2008 | US20080045480 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 02/21/2008 | US20080045475 Elemental cellular therapy is a genetic, cellular and disease-modifying therapy which enhances the systemic conduct of genetic and cellular transmethylation activity resulting in enhancement of concerted genetic and cellular metabolic, physiologic and homeostatic processes |
| 02/21/2008 | US20080045474 Method for treatment of invasive cells |
| 02/21/2008 | US20080045463 Methods For Lowering Hif-1 Mediated Gene Expression |
| 02/21/2008 | US20080045462 Use of pentagastrin to inhibit gastric acid secretion or as a diuretic |
| 02/21/2008 | US20080045461 N-terminally modified glp-1 receptor modulators |
| 02/21/2008 | US20080045460 Treatment of prostate cancer by inhibiting lyn-tyrosine kinase |
| 02/21/2008 | US20080045459 Orally administered peptides synergize statin activity |
| 02/21/2008 | US20080045458 synthetic polypeptides; isolated and purified from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for reducing wrinkles; inhibits calcium uptake; encoded from nucleic acid; analgesic or insecticide |
| 02/21/2008 | US20080045457 Ancestral Hepatitis C virus envelope protein sequence |
| 02/21/2008 | US20080045456 Use of wild type angiogenin |
| 02/21/2008 | US20080045455 RAGE fusion proteins, formulations, and methods of use thereof |
| 02/21/2008 | US20080045454 Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same |
| 02/21/2008 | US20080045453 Method of producing biologically active vitamin K dependent proteins by recombinant methods |
| 02/21/2008 | US20080045452 Regulation of Cytokine Synthesis and Release |
| 02/21/2008 | US20080045450 GLP-2 Derivatives |
| 02/21/2008 | US20080045449 Novel Lipid Mixtures For Synthetic Surfactants |
| 02/21/2008 | US20080045448 Reversing autonomic nervous system dysfunction by potentiating methylation |
| 02/21/2008 | US20080045447 Fibrilliform-free insulin composition |
| 02/21/2008 | US20080045446 Insulin composition |
| 02/21/2008 | US20080045445 Modulating Notch1 Signaling Pathway for Treating Neuroendocrine Tumors |
| 02/21/2008 | US20080045444 Compositions and methods for treating cardiovascular disease and myocardial infarction with dipeptidyl peptidase inhibitors or b type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation |
| 02/21/2008 | US20080045443 Compositions for Inhibiting plexin-A1-DAP12 interactions and Methods of Treating Inflammatory, Autoimmune or Bone Resorption Diseases Using the Same |
| 02/21/2008 | US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof |
| 02/21/2008 | US20080044837 antibody that binds to the extracellular portion of the human Programmed Death-1 (PD-1) receptor at a membrane proximal region; identifying a modulator of CD28 |
| 02/21/2008 | US20080044544 Milk protein isolate and process for its preparation |
| 02/21/2008 | US20080044503 A method for producing functional food aimed at blood pressure reduction from the hydrolyzed vegetable solution |
| 02/21/2008 | US20080044494 Skin care compositions containing silicone elastomers |
| 02/21/2008 | US20080044484 Use of polymeric nanoparticles for vaccine delivery |
| 02/21/2008 | US20080044473 Methods of reducing nervous system glial scar formation using cyclosporine components |
| 02/21/2008 | US20080044465 Therapy for cellular accumulation in chronic inflammatory diseases |
| 02/21/2008 | US20080044463 Bradykinin B2 Receptor Antagonist Peptide From Amphibian Skin |
| 02/21/2008 | US20080044459 Enzymatic debridement therapy for abnormal cell proliferation |
| 02/21/2008 | US20080044452 Drug delivery system for treatment of transitional cell carcinoma |